StockData

Indaptus Therapeutics, Inc. (INDP) stock

INDPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$3.32−0.13 (-3.77%)

Close on Nov 17, 2026Market cap $442.37MP/E –Yield –

Indaptus Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Indaptus Therapeutics's price to book ratio was 37.6× on Nov 11, 2026, against 0.8× a year earlier. Over the last 5 years it ranged from 0.4× to 37.6×, with a median of 1.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202637.6×+36.6
2025Dec 31, 20251.0×−0.4
2024Dec 31, 20241.4×+0.5
2023Dec 29, 20230.9×+0.5
2022Dec 30, 20220.4×−0.8
2021Dec 31, 20211.2×–

More Indaptus Therapeutics figures

See a number that looks wrong?